An interventional study of Brief, Integrated Intervention for Women Veterans with Unhealthy Alcohol Use in Primary Care in Unhealthy Alcohol Use, sponsored by Syracuse VA Medical Center. Not yet recruiting. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-24.
Sponsored by Syracuse VA Medical Center · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The goal of this study is to develop and test a brief behavioral treatment for women Veterans with alcohol use in primary care. The study involves an open trial phase to test the intervention with a small number of participants and revise the intervention based on experience and feedback. The main questions it aims to answer are:
Syracuse VA Medical Center is the lead sponsor of 11 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants in this arm will attend 4-9 30-minute behavioral health appointments with a behavioral health provider in an integrated primary care setting. All participants will attend 4 core alcohol-focused appointments focused on providing information and skills to manage unhealthy alcohol use. Participants may elect to attend up to 5 additional optional appointments focused on supplemental strategies to manage alcohol use or to address co-occurring mental and behavioral health concerns.
Behavioral: Brief, Integrated Intervention for Women Veterans with Unhealthy Alcohol Use in Primary Care
The intervention consists of 4-9 30-minute behavioral health appointments with a behavioral health provider in an integrated primary care setting. It includes 4 core alcohol-focused appointments focused on providing information and skills to manage unhealthy alcohol use that have been adapted from existing evidence-based treatments in integrated primary care and specialty care. Participants may elect to attend up to 5 additional optional appointments focused on supplemental strategies to manage alcohol use or to address co-occurring mental and behavioral health concerns, including mood, trauma, sleep, and pain.
Change in self-reported quality of life from baseline to post-treatment
Quality of life will be assessed by the abbreviated World Health Organization Quality of Life Assessment (WHOQOL-BREF), a 26-item self-report measure of QoL in the past 2 weeks in 4 areas (social, physical, psychological, and environment) on a 1-5 scale. Higher scores indicate better quality of life.
Time frame: Baseline to post-treatment (approximately 8-12 weeks after baseline)
Change in self-reported alcohol-related problems from baseline to post-treatment
Alcohol problems will be assessed by the Short Inventory of Problems-Revised (SIP-R)147, a 17-item self-report measure of frequency of alcohol problems on a 0-3 scale. Higher scores indicate more frequent alcohol-related problems.
Time frame: From baseline to post-treatment (approximately 8-12 weeks after baseline)
Change in self-reported alcohol-related functional impairment from baseline to post-treatment
Alcohol-specific functional impairment will be assessed by the Addiction Severity Index - Lite, a semi-structured interview developed among Veterans in substance use treatment that assesses alcohol and drug use and problems and 5 areas of functioning: medical, legal, psychiatric, employment, and family/social. Higher scores indicate greater alcohol-related functional impairment.
Time frame: Baseline to post-treatment (approximately 8-12 weeks after baseline)
Feasibility - average session length
Length of sessions will be measured to test if the average is within guidelines for integrated primary care treatment (30 minutes maximum)
Time frame: For the duration of the intervention period, 8-18 weeks post-baseline
Intervention fidelity
An independent rater will listen to session tapes and record if each essential element was delivered on a checklist.
Time frame: For the duration of the intervention period, 8-18 weeks post-baseline
Self-reported patient acceptability of the intervention
Patient acceptability will be assessed with the Client Satisfaction Questionnaire (CSQ), an 8-item self-report measure. Acceptability ratings of at least "moderate" on the majority (5/8) of items on the CSQ will be considered acceptable.
Time frame: After completing the behavioral health treatment, 8-18 weeks post-baseline
Self-reported change in alcohol consumption from baseline to post-treatment
Alcohol use will be assessed with the Timeline Followback (TLFB), a calendar-based measure that records standard drinks consumed each day in the past month to yield percent of drinking days, average drinks per drinking day, percent of heavy drinking (i.e., ≥4 drinks/occasion) days, and a variable indicating if alcohol use is above NIAAA-recommendations.
Time frame: Baseline to post-treatment (approximately 8-12 weeks after baseline).
No study locations are listed for this record.
Plan to share: Yes — Once all data collection is complete and the coded database is finalized, IPD will be shared according to PI discretion. For instance, IPD may be shared to be used in meta-analyses or other review papers. No identifiable participant information will be shared.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code
Time frame: The data will be available once the database is finalized and will remain available in the future.
Access criteria: Access to the data can be obtained by emailing the PIs and describing the reason the data is needed.
No publications or documents are linked to this record.
Start is estimated for Sep 2026; primary completion for Sep 2027, 12 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Syracuse VA Medical Center